Clinical Trial Update: A Registry Study of NanoKnife IRE for Stage 3 Pancreatic Cancer

View source ↗

Summary

A registry study evaluating the NanoKnife Irreversible Electroporation system for Stage III pancreatic cancer, sponsored by Angiodynamics, with status ACTIVE_NO…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• NanoKnife Irreversible Electroporation System (IRE)

Snippet

Sponsor: Angiodynamics, Inc. | Conditions: Stage III Pancreatic Cancer | Status: ACTIVE_NOT_RECRUITING